FDA Approved: DSUVIA — Supplemental Application (AcelRx Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for DSUVIA (sufentanil) from AcelRx Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• DSUVIA (SUFENTANIL)

Snippet

SUPPL AP for DSUVIA (SUFENTANIL)